| Elrexfio |
Human |
elranatamab |
elranatamab |
EMEA/H/C/005908 |
Pfizer Europe MA EEIG |
2023/12/07
|
Authorised |
| Veoza |
Human |
fezolinetant |
fezolinetant |
EMEA/H/C/005851 |
Astellas Pharma Europe B.V. |
2023/12/07
|
Authorised |
| Zilbrysq |
Human |
zilucoplan |
zilucoplan |
EMEA/H/C/005450 |
UCB Pharma S.A. |
2023/12/01
|
Authorised |
| Pylclari |
Human |
piflufolastat (18F) |
Piflufolastat (18F) |
EMEA/H/C/005520 |
Curium Pet France |
2023/11/27
|
Authorised |
| Yorvipath |
Human |
palopegteriparatide |
palopegteriparatide |
EMEA/H/C/005934 |
Ascendis Pharma Bone Diseases A/S |
2023/11/17
|
Authorised |
| Ebglyss |
Human |
lebrikizumab |
Lebrikizumab |
EMEA/H/C/005894 |
Almirall, S.A. |
2023/11/16
|
Authorised |
| Finlee |
Human |
dabrafenib |
dabrafenib mesilate |
EMEA/H/C/005885 |
Novartis Europharm Limited |
2023/11/15
|
Authorised |
| Aqumeldi |
Human |
enalapril maleate |
Enalapril (maleate) |
EMEA/H/C/005731 |
Proveca Pharma Limited |
2023/11/15
|
Authorised |
| Herwenda |
Human |
trastuzumab |
trastuzumab |
EMEA/H/C/005769 |
Sandoz GmbH |
2023/11/15
|
Authorised |
| Catiolanze |
Human |
latanoprost |
Latanoprost |
EMEA/H/C/005933 |
Santen Oy |
2023/11/15
|
Authorised |
| Vanflyta |
Human |
quizartinib |
quizartinib dihydrochloride |
EMEA/H/C/005910 |
Daiichi Sankyo Europe GmbH |
2023/11/06
|
Authorised |
| Jaypirca |
Human |
pirtobrutinib |
pirtobrutinib |
EMEA/H/C/005863 |
Eli Lilly Nederland B.V. |
2023/10/30
|
Authorised |
| Zoonotic Influenza Vaccine Seqirus |
Human |
zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted) |
A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b) |
EMEA/H/C/006375 |
Seqirus S.r.l. |
2023/10/09
|
Authorised |
| Degarelix Accord |
Human |
degarelix |
degarelix acetate |
EMEA/H/C/006048 |
Accord Healthcare S.L.U. |
2023/09/29
|
Authorised |
| Tepkinly |
Human |
epcoritamab |
epcoritamab |
EMEA/H/C/005985 |
AbbVie Deutschland GmbH & Co. KG |
2023/09/22
|
Authorised |
| Tyruko |
Human |
natalizumab |
natalizumab |
EMEA/H/C/005752 |
Sandoz GmbH |
2023/09/22
|
Authorised |
| Lyfnua |
Human |
gefapixant |
gefapixant |
EMEA/H/C/005476 |
Merck Sharp & Dohme B.V. |
2023/09/15
|
Authorised |
| Tevimbra |
Human |
tislelizumab |
tislelizumab |
EMEA/H/C/005919 |
Beone Medicines Ireland Limited |
2023/09/15
|
Authorised |
| Orserdu |
Human |
elacestrant |
elacestrant |
EMEA/H/C/005898 |
Stemline Therapeutics B.V. |
2023/09/15
|
Authorised |
| Tyenne |
Human |
tocilizumab |
tocilizumab |
EMEA/H/C/005781 |
Fresenius Kabi Deutschland GmbH |
2023/09/15
|
Authorised |
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
药物在线相关数据库
